Cipla reports Profit after tax of Rs 10296.90 Mln, in the September 2023 quarter

27 Oct 2023 Evaluate
The revenue for the September 2023 quarter is pegged at Rs. 46647.20 millions, about 12.37% up against Rs. 41512.70 millions recorded during the year-ago period.A comparatively good net profit growth of 46.02% to Rs. 10296.90 millions was reported for the quarter ended September 2023 compared to Rs. 7051.90 millions of previous same quarter.Operating profit surged to 15842.10 millions from the corresponding previous quarter of 11533.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 46647.20 41512.70 12.37 89829.10 79974.10 12.32 157906.00 153808.20 2.66
Other Income 2050.90 922.80 122.25 3630.70 2099.60 72.92 4567.90 6667.00 -31.48
PBIDT 15842.10 11533.30 37.36 29468.80 22646.50 30.13 42493.70 43779.30 -2.94
Interest 78.00 75.00 4.00 81.10 97.10 -16.48 270.20 269.30 0.33
PBDT 15764.10 11458.30 37.58 29387.70 22549.40 30.33 40364.50 43510.00 -7.23
Depreciation 1798.10 1760.10 2.16 3157.60 3043.70 3.74 5959.10 5466.20 9.02
PBT 13966.00 9698.20 44.01 26230.10 19505.70 34.47 34405.40 38043.80 -9.56
TAX 3669.10 2646.30 38.65 6983.00 5150.50 35.58 9710.10 9218.00 5.34
Deferred Tax -13.00 -6.00 116.67 -102.50 -95.30 7.56 -400.90 -276.90 44.78
PAT 10296.90 7051.90 46.02 19247.10 14355.20 34.08 24695.30 28825.80 -14.33
Equity 1614.70 1614.00 0.04 1614.70 1614.00 0.04 1614.30 1613.60 0.04
PBIDTM(%) 33.96 27.78 22.24 32.81 28.32 15.85 26.91 28.46 -5.46

Cipla Share Price

1405.40 6.60 (0.47%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.